Angiotensin II Receptors and Functional Correlates
Angiotensin II (ANG II) is the primary mediator of the renin-angiotensin system, which has an important functional role in cardiovascular homeostasis. The angiotensin receptor and its functional correlates have been redefined by the cloning of angiotensin receptors and the discovery and widespread s...
Gespeichert in:
Veröffentlicht in: | American journal of hypertension 1992-12, Vol.5 (12-Pt-2), p.221S-235S |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 235S |
---|---|
container_issue | 12-Pt-2 |
container_start_page | 221S |
container_title | American journal of hypertension |
container_volume | 5 |
creator | Timmermans, Pieter B.M.W.M. Benfield, Pamela Chiu, Andrew T. Herblin, William F. Wong, Pancras C. Smith, Ronald D. |
description | Angiotensin II (ANG II) is the primary mediator of the renin-angiotensin system, which has an important functional role in cardiovascular homeostasis. The angiotensin receptor and its functional correlates have been redefined by the cloning of angiotensin receptors and the discovery and widespread study of specific nonpeptide ANG II-receptor antagonists losartan (AT1 selective) and PD123177 (AT2 selective). With these antagonists, it has been possible to extend the concept of ANG II-receptor heterogeneity to virtually every tissue and species. The losartan-sensitive sites have been shown to mediate all of the major ANG II-induced biologic effects, including vasoconstriction, aldosterone and catecholamine release, and central, ANG II-induced drinking behavior. The function of the AT2 site is not fully understood, but it may be involved in neuronal ion channel modulation and in fibroblast collagen metabolism. The presence of AT2 sites in fetal tissues and in discrete locations in the brain has encouraged continued research. Losartan, which represents the first of a new class of therapeutic agents, is currently undergoing clinical trials. A growing number of other AT1-selective ANG II-receptor antagonists are under development, including L-158,809, SKF 108566, and GR117285. Rat AT1-receptor subtypes have been cloned and sequenced (AT1A and AT1B ) . Human ANG II receptors have also been cloned and shown to have high affinity for losartan. A number of atypical angiotensin-binding sites have been identified from mycoplasma, amphibians, and mouse neuroblastoma, which are not sensitive to either losartan or PD123177. Our view of the ANG II receptor continues to grow in its complexity, as losartan and other nonpeptide antagonists are used as tools to define the functional role(s) of ANG II. Am J Hypertens 1992;5:221S–235S |
doi_str_mv | 10.1093/ajh/5.12.221S |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73412210</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73412210</sourcerecordid><originalsourceid>FETCH-LOGICAL-c355t-fc80dbca957283f43d1d366cd19232c9979ff11112b89c6c7d3e2d18634810313</originalsourceid><addsrcrecordid>eNpNkEFPAjEQRhujQUSPHk32YLwtdNptuz0iimAwRtRovDSl29XFpYvtkui_dwkEncsk873MZB5Cp4C7gCXt6flHj3WBdAmBxz3UBplALAhh-6iNU8ligTkcoqMQ5hjjhHNooRYQ2UxFG5G-ey-q2rpQuGg8jqbW2GVd-RBpl0XDlTN1UTldRoPKe1vq2oZjdJDrMtiTbe-g5-H102AUT-5vxoP-JDaUsTrOTYqzmdGSCZLSPKEZZJRzk4EklBgphcxzaIrMUmm4ERm1JIOU0yQFTIF20MVm79JXXysbarUogrFlqZ2tVkEJmkDzM27AeAMaX4Xgba6Wvlho_6MAq7Uj1ThSTAFRa0cNf7ZdvJotbPZHb6Q0-fk218HoMvfamSLssIRRmtB_Z4tQ2-9drP2n4oIKpkavb-pqevcyusS36oH-AlOGfEU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73412210</pqid></control><display><type>article</type><title>Angiotensin II Receptors and Functional Correlates</title><source>MEDLINE</source><source>Oxford University Press Journals Digital Archive Legacy</source><creator>Timmermans, Pieter B.M.W.M. ; Benfield, Pamela ; Chiu, Andrew T. ; Herblin, William F. ; Wong, Pancras C. ; Smith, Ronald D.</creator><creatorcontrib>Timmermans, Pieter B.M.W.M. ; Benfield, Pamela ; Chiu, Andrew T. ; Herblin, William F. ; Wong, Pancras C. ; Smith, Ronald D.</creatorcontrib><description>Angiotensin II (ANG II) is the primary mediator of the renin-angiotensin system, which has an important functional role in cardiovascular homeostasis. The angiotensin receptor and its functional correlates have been redefined by the cloning of angiotensin receptors and the discovery and widespread study of specific nonpeptide ANG II-receptor antagonists losartan (AT1 selective) and PD123177 (AT2 selective). With these antagonists, it has been possible to extend the concept of ANG II-receptor heterogeneity to virtually every tissue and species. The losartan-sensitive sites have been shown to mediate all of the major ANG II-induced biologic effects, including vasoconstriction, aldosterone and catecholamine release, and central, ANG II-induced drinking behavior. The function of the AT2 site is not fully understood, but it may be involved in neuronal ion channel modulation and in fibroblast collagen metabolism. The presence of AT2 sites in fetal tissues and in discrete locations in the brain has encouraged continued research. Losartan, which represents the first of a new class of therapeutic agents, is currently undergoing clinical trials. A growing number of other AT1-selective ANG II-receptor antagonists are under development, including L-158,809, SKF 108566, and GR117285. Rat AT1-receptor subtypes have been cloned and sequenced (AT1A and AT1B ) . Human ANG II receptors have also been cloned and shown to have high affinity for losartan. A number of atypical angiotensin-binding sites have been identified from mycoplasma, amphibians, and mouse neuroblastoma, which are not sensitive to either losartan or PD123177. Our view of the ANG II receptor continues to grow in its complexity, as losartan and other nonpeptide antagonists are used as tools to define the functional role(s) of ANG II. Am J Hypertens 1992;5:221S–235S</description><identifier>ISSN: 0895-7061</identifier><identifier>EISSN: 1941-7225</identifier><identifier>EISSN: 1879-1905</identifier><identifier>DOI: 10.1093/ajh/5.12.221S</identifier><identifier>PMID: 1290617</identifier><language>eng</language><publisher>New York, NY: Oxford University Press</publisher><subject>Acrylates - therapeutic use ; Angiotensin II ; angiotensin II receptor ; Angiotensin Receptor Antagonists ; Antihypertensive agents ; Antihypertensive Agents - therapeutic use ; Biological and medical sciences ; Biphenyl Compounds - therapeutic use ; Blood Pressure - physiology ; Cardiovascular system ; Humans ; Hypertension - drug therapy ; Hypertension - physiopathology ; Imidazoles - therapeutic use ; Losartan ; losartan (DuP 753) ; Medical sciences ; Pharmacology. Drug treatments ; Pyridines - therapeutic use ; Receptors, Angiotensin - physiology ; renin-angiotensin system ; Renin-Angiotensin System - drug effects ; Renin-Angiotensin System - physiology ; Tetrazoles - therapeutic use ; Thiophenes</subject><ispartof>American journal of hypertension, 1992-12, Vol.5 (12-Pt-2), p.221S-235S</ispartof><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c355t-fc80dbca957283f43d1d366cd19232c9979ff11112b89c6c7d3e2d18634810313</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4533430$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1290617$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Timmermans, Pieter B.M.W.M.</creatorcontrib><creatorcontrib>Benfield, Pamela</creatorcontrib><creatorcontrib>Chiu, Andrew T.</creatorcontrib><creatorcontrib>Herblin, William F.</creatorcontrib><creatorcontrib>Wong, Pancras C.</creatorcontrib><creatorcontrib>Smith, Ronald D.</creatorcontrib><title>Angiotensin II Receptors and Functional Correlates</title><title>American journal of hypertension</title><addtitle>AJH</addtitle><description>Angiotensin II (ANG II) is the primary mediator of the renin-angiotensin system, which has an important functional role in cardiovascular homeostasis. The angiotensin receptor and its functional correlates have been redefined by the cloning of angiotensin receptors and the discovery and widespread study of specific nonpeptide ANG II-receptor antagonists losartan (AT1 selective) and PD123177 (AT2 selective). With these antagonists, it has been possible to extend the concept of ANG II-receptor heterogeneity to virtually every tissue and species. The losartan-sensitive sites have been shown to mediate all of the major ANG II-induced biologic effects, including vasoconstriction, aldosterone and catecholamine release, and central, ANG II-induced drinking behavior. The function of the AT2 site is not fully understood, but it may be involved in neuronal ion channel modulation and in fibroblast collagen metabolism. The presence of AT2 sites in fetal tissues and in discrete locations in the brain has encouraged continued research. Losartan, which represents the first of a new class of therapeutic agents, is currently undergoing clinical trials. A growing number of other AT1-selective ANG II-receptor antagonists are under development, including L-158,809, SKF 108566, and GR117285. Rat AT1-receptor subtypes have been cloned and sequenced (AT1A and AT1B ) . Human ANG II receptors have also been cloned and shown to have high affinity for losartan. A number of atypical angiotensin-binding sites have been identified from mycoplasma, amphibians, and mouse neuroblastoma, which are not sensitive to either losartan or PD123177. Our view of the ANG II receptor continues to grow in its complexity, as losartan and other nonpeptide antagonists are used as tools to define the functional role(s) of ANG II. Am J Hypertens 1992;5:221S–235S</description><subject>Acrylates - therapeutic use</subject><subject>Angiotensin II</subject><subject>angiotensin II receptor</subject><subject>Angiotensin Receptor Antagonists</subject><subject>Antihypertensive agents</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Biphenyl Compounds - therapeutic use</subject><subject>Blood Pressure - physiology</subject><subject>Cardiovascular system</subject><subject>Humans</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - physiopathology</subject><subject>Imidazoles - therapeutic use</subject><subject>Losartan</subject><subject>losartan (DuP 753)</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyridines - therapeutic use</subject><subject>Receptors, Angiotensin - physiology</subject><subject>renin-angiotensin system</subject><subject>Renin-Angiotensin System - drug effects</subject><subject>Renin-Angiotensin System - physiology</subject><subject>Tetrazoles - therapeutic use</subject><subject>Thiophenes</subject><issn>0895-7061</issn><issn>1941-7225</issn><issn>1879-1905</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkEFPAjEQRhujQUSPHk32YLwtdNptuz0iimAwRtRovDSl29XFpYvtkui_dwkEncsk873MZB5Cp4C7gCXt6flHj3WBdAmBxz3UBplALAhh-6iNU8ligTkcoqMQ5hjjhHNooRYQ2UxFG5G-ey-q2rpQuGg8jqbW2GVd-RBpl0XDlTN1UTldRoPKe1vq2oZjdJDrMtiTbe-g5-H102AUT-5vxoP-JDaUsTrOTYqzmdGSCZLSPKEZZJRzk4EklBgphcxzaIrMUmm4ERm1JIOU0yQFTIF20MVm79JXXysbarUogrFlqZ2tVkEJmkDzM27AeAMaX4Xgba6Wvlho_6MAq7Uj1ThSTAFRa0cNf7ZdvJotbPZHb6Q0-fk218HoMvfamSLssIRRmtB_Z4tQ2-9drP2n4oIKpkavb-pqevcyusS36oH-AlOGfEU</recordid><startdate>19921201</startdate><enddate>19921201</enddate><creator>Timmermans, Pieter B.M.W.M.</creator><creator>Benfield, Pamela</creator><creator>Chiu, Andrew T.</creator><creator>Herblin, William F.</creator><creator>Wong, Pancras C.</creator><creator>Smith, Ronald D.</creator><general>Oxford University Press</general><general>Elsevier Science</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19921201</creationdate><title>Angiotensin II Receptors and Functional Correlates</title><author>Timmermans, Pieter B.M.W.M. ; Benfield, Pamela ; Chiu, Andrew T. ; Herblin, William F. ; Wong, Pancras C. ; Smith, Ronald D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c355t-fc80dbca957283f43d1d366cd19232c9979ff11112b89c6c7d3e2d18634810313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Acrylates - therapeutic use</topic><topic>Angiotensin II</topic><topic>angiotensin II receptor</topic><topic>Angiotensin Receptor Antagonists</topic><topic>Antihypertensive agents</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Biphenyl Compounds - therapeutic use</topic><topic>Blood Pressure - physiology</topic><topic>Cardiovascular system</topic><topic>Humans</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - physiopathology</topic><topic>Imidazoles - therapeutic use</topic><topic>Losartan</topic><topic>losartan (DuP 753)</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyridines - therapeutic use</topic><topic>Receptors, Angiotensin - physiology</topic><topic>renin-angiotensin system</topic><topic>Renin-Angiotensin System - drug effects</topic><topic>Renin-Angiotensin System - physiology</topic><topic>Tetrazoles - therapeutic use</topic><topic>Thiophenes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Timmermans, Pieter B.M.W.M.</creatorcontrib><creatorcontrib>Benfield, Pamela</creatorcontrib><creatorcontrib>Chiu, Andrew T.</creatorcontrib><creatorcontrib>Herblin, William F.</creatorcontrib><creatorcontrib>Wong, Pancras C.</creatorcontrib><creatorcontrib>Smith, Ronald D.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Timmermans, Pieter B.M.W.M.</au><au>Benfield, Pamela</au><au>Chiu, Andrew T.</au><au>Herblin, William F.</au><au>Wong, Pancras C.</au><au>Smith, Ronald D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Angiotensin II Receptors and Functional Correlates</atitle><jtitle>American journal of hypertension</jtitle><addtitle>AJH</addtitle><date>1992-12-01</date><risdate>1992</risdate><volume>5</volume><issue>12-Pt-2</issue><spage>221S</spage><epage>235S</epage><pages>221S-235S</pages><issn>0895-7061</issn><eissn>1941-7225</eissn><eissn>1879-1905</eissn><abstract>Angiotensin II (ANG II) is the primary mediator of the renin-angiotensin system, which has an important functional role in cardiovascular homeostasis. The angiotensin receptor and its functional correlates have been redefined by the cloning of angiotensin receptors and the discovery and widespread study of specific nonpeptide ANG II-receptor antagonists losartan (AT1 selective) and PD123177 (AT2 selective). With these antagonists, it has been possible to extend the concept of ANG II-receptor heterogeneity to virtually every tissue and species. The losartan-sensitive sites have been shown to mediate all of the major ANG II-induced biologic effects, including vasoconstriction, aldosterone and catecholamine release, and central, ANG II-induced drinking behavior. The function of the AT2 site is not fully understood, but it may be involved in neuronal ion channel modulation and in fibroblast collagen metabolism. The presence of AT2 sites in fetal tissues and in discrete locations in the brain has encouraged continued research. Losartan, which represents the first of a new class of therapeutic agents, is currently undergoing clinical trials. A growing number of other AT1-selective ANG II-receptor antagonists are under development, including L-158,809, SKF 108566, and GR117285. Rat AT1-receptor subtypes have been cloned and sequenced (AT1A and AT1B ) . Human ANG II receptors have also been cloned and shown to have high affinity for losartan. A number of atypical angiotensin-binding sites have been identified from mycoplasma, amphibians, and mouse neuroblastoma, which are not sensitive to either losartan or PD123177. Our view of the ANG II receptor continues to grow in its complexity, as losartan and other nonpeptide antagonists are used as tools to define the functional role(s) of ANG II. Am J Hypertens 1992;5:221S–235S</abstract><cop>New York, NY</cop><pub>Oxford University Press</pub><pmid>1290617</pmid><doi>10.1093/ajh/5.12.221S</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0895-7061 |
ispartof | American journal of hypertension, 1992-12, Vol.5 (12-Pt-2), p.221S-235S |
issn | 0895-7061 1941-7225 1879-1905 |
language | eng |
recordid | cdi_proquest_miscellaneous_73412210 |
source | MEDLINE; Oxford University Press Journals Digital Archive Legacy |
subjects | Acrylates - therapeutic use Angiotensin II angiotensin II receptor Angiotensin Receptor Antagonists Antihypertensive agents Antihypertensive Agents - therapeutic use Biological and medical sciences Biphenyl Compounds - therapeutic use Blood Pressure - physiology Cardiovascular system Humans Hypertension - drug therapy Hypertension - physiopathology Imidazoles - therapeutic use Losartan losartan (DuP 753) Medical sciences Pharmacology. Drug treatments Pyridines - therapeutic use Receptors, Angiotensin - physiology renin-angiotensin system Renin-Angiotensin System - drug effects Renin-Angiotensin System - physiology Tetrazoles - therapeutic use Thiophenes |
title | Angiotensin II Receptors and Functional Correlates |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T11%3A58%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Angiotensin%20II%20Receptors%20and%20Functional%20Correlates&rft.jtitle=American%20journal%20of%20hypertension&rft.au=Timmermans,%20Pieter%20B.M.W.M.&rft.date=1992-12-01&rft.volume=5&rft.issue=12-Pt-2&rft.spage=221S&rft.epage=235S&rft.pages=221S-235S&rft.issn=0895-7061&rft.eissn=1941-7225&rft_id=info:doi/10.1093/ajh/5.12.221S&rft_dat=%3Cproquest_cross%3E73412210%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73412210&rft_id=info:pmid/1290617&rfr_iscdi=true |